Turning translational academic research into medicines for patients with genetic diseases
1200-1330 Webinar BridgeBio is a pharmaceutical company that finds, develops and delivers breakthrough medicines for genetic diseases. Founded in 2015 by a team of industry veterans, the company has built a portfolio of over 30 development programmes ranging from discovery to Phase 3 clinical trials with two approved products. The company’s therapeutic areas include genetic […]